Post-treatment (not interim) positron emission tomography-computed tomography scan status is highly predictive of outcome in mantle cell lymphoma patients treated with R-HyperCVAD
Cancer, 05/02/2012Mato AR et al.
The data do not support the prognostic utility of positron emission tomographic (PET)–computed tomographic (CT) in pretreatment and interim treatment settings. A positive PET–CT after the completion of therapy identifies a patient subset with an inferior progression–free survival (PFS) and a trend toward inferior overall survival (OS).
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.